David Van Wyck

2.5k total citations
31 papers, 1.6k citations indexed

About

David Van Wyck is a scholar working on Hematology, Nephrology and Genetics. According to data from OpenAlex, David Van Wyck has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Nephrology and 8 papers in Genetics. Recurrent topics in David Van Wyck's work include Iron Metabolism and Disorders (10 papers), Dialysis and Renal Disease Management (10 papers) and Erythropoietin and Anemia Treatment (9 papers). David Van Wyck is often cited by papers focused on Iron Metabolism and Disorders (10 papers), Dialysis and Renal Disease Management (10 papers) and Erythropoietin and Anemia Treatment (9 papers). David Van Wyck collaborates with scholars based in United States, United Kingdom and Germany. David Van Wyck's co-authors include Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Deborah L. Regidor, Rajnish Mehrotra, Joel D. Kopple, Tamara B. Horwich, Suphamai Bunnapradist, Gregg C. Fonarow, Sander Greenland and Christian S. Shinaberger and has published in prestigious journals such as Circulation, American Journal of Clinical Nutrition and Kidney International.

In The Last Decade

David Van Wyck

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Van Wyck United States 14 999 536 308 272 163 31 1.6k
Jane Y. Yeun United States 14 1.3k 1.3× 411 0.8× 93 0.3× 499 1.8× 200 1.2× 21 1.8k
J. Bommer Germany 15 1.3k 1.3× 406 0.8× 111 0.4× 343 1.3× 196 1.2× 31 1.7k
E. Lars Penne Netherlands 25 1.3k 1.3× 322 0.6× 149 0.5× 600 2.2× 175 1.1× 48 1.8k
John C. Stivelman United States 12 756 0.8× 318 0.6× 142 0.5× 253 0.9× 297 1.8× 16 1.1k
Nobuhiko Joki Japan 25 991 1.0× 254 0.5× 126 0.4× 371 1.4× 374 2.3× 98 1.8k
Lloyd S. Ibels Australia 22 1.6k 1.6× 635 1.2× 206 0.7× 471 1.7× 209 1.3× 37 2.6k
Morrell M. Avram United States 28 1.6k 1.6× 516 1.0× 143 0.5× 562 2.1× 206 1.3× 76 2.4k
Euan Carlisle Canada 15 1.3k 1.3× 428 0.8× 149 0.5× 216 0.8× 450 2.8× 19 2.0k
Ángel L.M. de Francisco Spain 25 910 0.9× 244 0.5× 106 0.3× 432 1.6× 215 1.3× 117 1.9k
Fernando de Álvaro Spain 20 873 0.9× 288 0.5× 96 0.3× 306 1.1× 501 3.1× 57 1.7k

Countries citing papers authored by David Van Wyck

Since Specialization
Citations

This map shows the geographic impact of David Van Wyck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Van Wyck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Van Wyck more than expected).

Fields of papers citing papers by David Van Wyck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Van Wyck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Van Wyck. The network helps show where David Van Wyck may publish in the future.

Co-authorship network of co-authors of David Van Wyck

This figure shows the co-authorship network connecting the top 25 collaborators of David Van Wyck. A scholar is included among the top collaborators of David Van Wyck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Van Wyck. David Van Wyck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laskowitz, Daniel T. & David Van Wyck. (2023). ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury. Neurotherapeutics. 20(6). 1496–1507. 2 indexed citations
2.
Wyck, David Van, et al.. (2022). Prophylactic treatment with CN-105 improves functional outcomes in a murine model of closed head injury. Experimental Brain Research. 240(9). 2413–2423. 3 indexed citations
3.
Brunelli, Steven M., et al.. (2019). Safety and efficacy of heparin during dialysis in the context of systemic anticoagulant and antiplatelet medications. Journal of Nephrology. 32(3). 453–460. 6 indexed citations
4.
Brunelli, Steven M., et al.. (2018). The Impact of Midodrine on Outcomes in Patients with Intradialytic Hypotension. American Journal of Nephrology. 48(5). 381–388. 25 indexed citations
5.
Macdougall, Iain C., Andreas Böck, Fernando Carrera, et al.. (2017). Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial. BMC Nephrology. 18(1). 24–24. 12 indexed citations
6.
Brunelli, Steven M., Scott Sibbel, David Van Wyck, et al.. (2017). Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model. Drugs in R&D. 17(1). 159–166. 2 indexed citations
7.
Macdougall, Iain C., A. Böck, Fernando Carrera, et al.. (2014). FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrology Dialysis Transplantation. 29(11). 2075–2084. 207 indexed citations
8.
Friedman, Arnold J., Zhao Chen, Patricia Ford, et al.. (2012). Iron Deficiency Anemia in Women Across the Life Span. Journal of Women s Health. 21(12). 1282–1289. 45 indexed citations
9.
Benner, Debbie, Allen R. Nissenson, & David Van Wyck. (2012). FOCUSED CLINICAL CAMPAIGN IMPROVES MINERAL AND BONE DISORDER OUTCOMES. Journal of Renal Care. 38(1). 2–8. 4 indexed citations
10.
Chen, Zhao, Cynthia A. Thomson, Mikel Aickin, et al.. (2010). The Relationship Between Incidence of Fractures and Anemia in Older Multiethnic Women. Journal of the American Geriatrics Society. 58(12). 2337–2344. 45 indexed citations
11.
Kalantar‐Zadeh, Kamyar, Deborah L. Regidor, Csaba P. Kövesdy, et al.. (2009). Fluid Retention Is Associated With Cardiovascular Mortality in Patients Undergoing Long-Term Hemodialysis. Circulation. 119(5). 671–679. 406 indexed citations
12.
Wyck, David Van, et al.. (2009). Relationship among Length of Facility Ownership, Clinical Performance, and Mortality. Clinical Journal of the American Society of Nephrology. 5(2). 248–251. 8 indexed citations
13.
Miller, Jessica E., Csaba P. Kövesdy, Allen R. Nissenson, et al.. (2009). Association of Hemodialysis Treatment Time and Dose With Mortality and the Role of Race and Sex. American Journal of Kidney Diseases. 55(1). 100–112. 92 indexed citations
14.
Regidor, Deborah L., Csaba P. Kövesdy, Rajnish Mehrotra, et al.. (2008). Serum Alkaline Phosphatase Predicts Mortality among Maintenance Hemodialysis Patients. Journal of the American Society of Nephrology. 19(11). 2193–2203. 209 indexed citations
15.
Shinaberger, Christian S., Sander Greenland, Joel D. Kopple, et al.. (2008). Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. American Journal of Clinical Nutrition. 88(6). 1511–1518. 236 indexed citations
16.
Shinaberger, Christian S., Joel D. Kopple, Csaba P. Kövesdy, et al.. (2008). Ratio of Paricalcitol Dosage to Serum Parathyroid Hormone Level and Survival in Maintenance Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 3(6). 1769–1776. 53 indexed citations
17.
Wyck, David Van, Kai‐Uwe Eckardt, Katrin Uhlig, Michael V. Rocco, & Adeera Levin. (2006). Appraisal of Evidence and Control of Bias in the Kidney Disease Outcomes Quality Initiative Guideline Development Process. Clinical Journal of the American Society of Nephrology. 2(1). 8–10. 7 indexed citations
18.
Aronoff, George R., William M. Bennett, Samuel S. Blumenthal, et al.. (2004). Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens. Kidney International. 66(3). 1193–1198. 73 indexed citations
19.
Wyck, David Van, Jaime Anderson, & Kevin Johnson. (2004). Labile iron in parenteral iron formulations: a quantitative and comparative study. Nephrology Dialysis Transplantation. 19(3). 561–565. 86 indexed citations
20.
Siskind, Mark S., et al.. (1993). The Effect of Dialyzer Reprocessing on Performance and β2-Microglobulin Removal Using Polysulfone Membranes. American Journal of Kidney Diseases. 21(4). 405–410. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane Y. Yeun Breakdown of academic impact, for papers by J. Bommer Breakdown of academic impact, for papers by E. Lars Penne Breakdown of academic impact, for papers by John C. Stivelman Breakdown of academic impact, for papers by Nobuhiko Joki Breakdown of academic impact, for papers by Lloyd S. Ibels Breakdown of academic impact, for papers by Morrell M. Avram Breakdown of academic impact, for papers by Euan Carlisle Breakdown of academic impact, for papers by Ángel L.M. de Francisco Breakdown of academic impact, for papers by Fernando de Álvaro
Rankless by CCL
2026